CERS Q1 2025 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$43M+12.7% YoY

Gross Profit

$25M58.8% margin

Operating Income

-$6M-13.5% margin

Net Income

-$8M-17.8% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-14.9%

Cash Flow

Operating Cash Flow

-$844,000

Free Cash Flow

-$956,000

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$207M

Total Liabilities

$151M

Stockholders' Equity

$55M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$38M	+12.7%
Gross Profit	$25M	$21M	+19.5%
Operating Income	-$6M	-$8M	+26.6%
Net Income	-$8M	-$10M	+20.3%

Revenue Segments

Product

$43M100%

Geographic Segments

North America

$31M71%

Europe Middle East And Africa

$12M28%

Other

$427,0001%